{"transactions":[{"id":1483094,"issuer":{"id":5638,"kind":"organization","name":"X4 Pharmaceuticals, Inc","symbol":"XFOR"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-11T20:13:25.000Z","date":"2024-06-10","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (RSUs) granted to the Reporting Person as an annual award for service on the Board of Directors. The RSUs will vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) the Issuer's next annual meeting of stockholders, subject to continued board service through the applicable vesting date. The RSUs will vest in full upon the occurrence of a change in control of the Issuer."}],"balance_after":96667,"source":{"system":"sec-edgar","filing":"0001628280-24-027677","document":"wk-form4_1718136796.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501697/000162828024027677/wk-form4_1718136796.xml","form_type":"4"}},{"id":1855582,"issuer":{"id":5638,"kind":"organization","name":"X4 Pharmaceuticals, Inc","symbol":"XFOR"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-14T21:10:34.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (?RSUs?) granted to the Reporting Person as an annual award for service on the Board of Directors. The RSUs will vest in full on the earlier of (i) the one-year anniversary of the grant date or (ii) the Issuer?s next annual meeting of stockholders, subject to continued board service through the applicable vesting date. The RSUs will vest in full upon the occurrence of a change in control of the Issuer."}],"balance_after":51667,"source":{"system":"sec-edgar","filing":"0001628280-23-022099","document":"wk-form4_1686777025.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501697/000162828023022099/wk-form4_1686777025.xml","form_type":"4"}},{"id":2099908,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-01T09:21:19.000Z","date":"2022-11-30","kind":"disposition_to_issuer","acquired":false,"shares":14000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":2.17,"expiration_date":"2031-11-30","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001062993-22-023027","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000106299322023027/form4.xml","form_type":"4"}},{"id":2099907,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-01T09:21:19.000Z","date":"2022-11-30","kind":"disposition_to_issuer","acquired":false,"shares":12000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":4.72,"expiration_date":"2030-12-16","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001062993-22-023027","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000106299322023027/form4.xml","form_type":"4"}},{"id":2099906,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-01T09:21:19.000Z","date":"2022-11-30","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":3.02,"expiration_date":"2029-12-04","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001062993-22-023027","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000106299322023027/form4.xml","form_type":"4"}},{"id":2099905,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-01T09:21:19.000Z","date":"2022-11-30","kind":"disposition_to_issuer","acquired":false,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":6.9,"expiration_date":"2028-11-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001062993-22-023027","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000106299322023027/form4.xml","form_type":"4"}},{"id":2099904,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-12-01T09:21:19.000Z","date":"2022-11-30","kind":"disposition_to_issuer","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"At the effective time of the Merger, each outstanding option of the Issuer with an exercise price equal to or greater than $0.34 was cancelled without any consideration in respect of such cancelled option."}],"balance_after":0,"derivative":{"exercise_price":4.4,"expiration_date":"2028-09-20","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001062993-22-023027","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000106299322023027/form4.xml","form_type":"4"}},{"id":2099903,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-01T09:21:19.000Z","date":"2022-11-30","kind":"other","acquired":false,"shares":8500,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Includes 1,500 shares held by the Reporting Person's wife in a self-directed IRA."},{"field":"shares","element":"transactionShares","label":"F2","text":"At the effective time of the Merger, each issued and outstanding Share was cancelled in exchange for (1) $0.34 per share of common stock of the Issuer (\"Common Stock\"), without interest and less any applicable withholding taxes  (the \"Cash Consideration\"); and (2) one contingent value right (\"CVR\") per share of Common Stock representing the right to receive potential milestone payments, currently estimated to be up to approximately $0.73 per CVR in the aggregate (without interest and less any applicable withholding taxes) (the Cash Consideration plus one CVR, collectively, as such amount may be increased in accordance with the terms of the Merger Agreement, the \"Offer Price\"). Pursuant to the terms of the Merger Agreement, the Shares were tendered and disposed of at the Acceptance Time (as defined in the Merger Agreement) in exchange for the right to receive the Offer Price."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Merger, each issued and outstanding Share was cancelled in exchange for (1) $0.34 per share of common stock of the Issuer (\"Common Stock\"), without interest and less any applicable withholding taxes  (the \"Cash Consideration\"); and (2) one contingent value right (\"CVR\") per share of Common Stock representing the right to receive potential milestone payments, currently estimated to be up to approximately $0.73 per CVR in the aggregate (without interest and less any applicable withholding taxes) (the Cash Consideration plus one CVR, collectively, as such amount may be increased in accordance with the terms of the Merger Agreement, the \"Offer Price\"). Pursuant to the terms of the Merger Agreement, the Shares were tendered and disposed of at the Acceptance Time (as defined in the Merger Agreement) in exchange for the right to receive the Offer Price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001062993-22-023027","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000106299322023027/form4.xml","form_type":"4"}},{"id":2220923,"issuer":{"id":5638,"kind":"organization","name":"X4 Pharmaceuticals, Inc","symbol":"XFOR"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-27T20:15:31.000Z","date":"2022-06-06","kind":"grant","acquired":true,"shares":6667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual grant of restricted stock units (\"RSUs\") for service as a director to the Issuer. The RSUs will vest in two equal annual installments on June 6, 2023 and June 6, 2024, subject to the Reporting Person continuing to provide service to the Issuer through the applicable vesting dates."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents unvested RSUs."}],"balance_after":6667,"source":{"system":"sec-edgar","filing":"0001628280-22-018048","document":"wf-form4_165636091026183.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501697/000162828022018048/wf-form4_165636091026183.xml","form_type":"4"}},{"id":2488450,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-12-02T18:43:17.000Z","date":"2021-11-30","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable in equal monthly installments over one year from the date of grant."}],"balance_after":14000,"derivative":{"exercise_price":2.17,"expiration_date":"2031-11-30","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001062993-21-012049","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000106299321012049/form4.xml","form_type":"4"}},{"id":2653129,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-28T22:26:31.000Z","date":"2021-06-24","kind":"grant","acquired":true,"shares":4125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2022."}],"balance_after":4125,"derivative":{"exercise_price":93.2,"expiration_date":"2031-06-24","underlying":"Common Stock","underlying_shares":4125},"source":{"system":"sec-edgar","filing":"0001209191-21-043547","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919121043547/doc4.xml","form_type":"4"}},{"id":2653128,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-28T22:26:31.000Z","date":"2021-06-24","kind":"grant","acquired":true,"shares":2145,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 24, 2022."}],"balance_after":66849,"source":{"system":"sec-edgar","filing":"0001209191-21-043547","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919121043547/doc4.xml","form_type":"4"}},{"id":2685951,"issuer":{"id":5638,"kind":"organization","name":"X4 Pharmaceuticals, Inc","symbol":"XFOR"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-02T21:03:55.000Z","date":"2021-06-02","kind":"grant","acquired":true,"shares":6000,"price":9.5,"value":57000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"8.3333% of the shares subject to the option shall vest on July 2, 2021, with the remainder vesting in equal monthly installments of 8.333% of the shares subject to the option until the 12-month anniversary of the date of the grant (or, if earlier, the date of the Issuer's next annual meeting of stockholders following the date of the grant) subject to the Reporting Person continuing to provide services through each such date."}],"balance_after":6000,"derivative":{"exercise_price":9.5,"expiration_date":"2031-06-02","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001628280-21-011546","document":"wf-form4_162266781755759.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501697/000162828021011546/wf-form4_162266781755759.xml","form_type":"4"}},{"id":2838392,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-02-23T19:30:24.000Z","date":"2021-02-19","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option vested in full on on June 9, 2016."}],"balance_after":0,"derivative":{"exercise_price":97.85,"expiration_date":"2025-06-18","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-21-013100","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919121013100/doc4.xml","form_type":"4"}},{"id":2838391,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-23T19:30:24.000Z","date":"2021-02-23","kind":"gift","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":64704,"source":{"system":"sec-edgar","filing":"0001209191-21-013100","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919121013100/doc4.xml","form_type":"4"}},{"id":2838390,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-23T19:30:24.000Z","date":"2021-02-19","kind":"sale","acquired":false,"shares":7500,"price":149.01,"value":1117575.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.00 to $149.15 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":65704,"source":{"system":"sec-edgar","filing":"0001209191-21-013100","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919121013100/doc4.xml","form_type":"4"}},{"id":2838389,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-23T19:30:24.000Z","date":"2021-02-19","kind":"exercise","acquired":true,"shares":7500,"price":97.85,"value":733875.0,"ownership":{"direct":true},"balance_after":73204,"source":{"system":"sec-edgar","filing":"0001209191-21-013100","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919121013100/doc4.xml","form_type":"4"}},{"id":2880923,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-04T01:02:28.000Z","date":"2020-08-27","kind":"gift","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects transfers of shares of common stock received from the Reporting Person's trust to the Reporting Person."}],"balance_after":65704,"source":{"system":"sec-edgar","filing":"0001209191-21-007553","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919121007553/doc5.xml","form_type":"5"}},{"id":2880922,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-04T01:02:28.000Z","date":"2020-05-21","kind":"gift","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":65704,"source":{"system":"sec-edgar","filing":"0001209191-21-007553","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919121007553/doc5.xml","form_type":"5"}},{"id":2937622,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-12-18T17:15:32.000Z","date":"2020-12-16","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable in equal monthly installments over one year from the date of grant."}],"balance_after":12000,"derivative":{"exercise_price":4.72,"expiration_date":"2030-12-16","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001273636-20-000009","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000127363620000009/edgar.xml","form_type":"4"}},{"id":3047388,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-25T19:56:56.000Z","date":"2020-08-21","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vested in full on June 11, 2020, the first anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":58.74,"expiration_date":"2029-06-11","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-20-048205","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120048205/doc4.xml","form_type":"4"}},{"id":3047387,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-25T19:56:56.000Z","date":"2020-08-21","kind":"sale","acquired":false,"shares":5000,"price":86.57,"value":432850.0,"ownership":{"direct":true},"balance_after":57018,"source":{"system":"sec-edgar","filing":"0001209191-20-048205","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120048205/doc4.xml","form_type":"4"}},{"id":3047386,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-25T19:56:56.000Z","date":"2020-08-21","kind":"exercise","acquired":true,"shares":5000,"price":58.74,"value":293700.0,"ownership":{"direct":true},"balance_after":62018,"source":{"system":"sec-edgar","filing":"0001209191-20-048205","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120048205/doc4.xml","form_type":"4"}},{"id":3096342,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-30T17:10:10.000Z","date":"2020-06-26","kind":"grant","acquired":true,"shares":4250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 26, 2021."}],"balance_after":4250,"derivative":{"exercise_price":76.58,"expiration_date":"2030-06-26","underlying":"Common Stock","underlying_shares":4250},"source":{"system":"sec-edgar","filing":"0001209191-20-039403","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120039403/doc4.xml","form_type":"4"}},{"id":3096341,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-30T17:10:10.000Z","date":"2020-06-26","kind":"grant","acquired":true,"shares":2550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 26, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects transfers of shares of common stock received from the  Reporting Person's trust to the Reporting Person that have taken place since the most recent prior report on Form 4."}],"balance_after":57018,"source":{"system":"sec-edgar","filing":"0001209191-20-039403","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120039403/doc4.xml","form_type":"4"}},{"id":3113018,"issuer":{"id":5638,"kind":"organization","name":"X4 Pharmaceuticals, Inc","symbol":"XFOR"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-11T12:34:21.000Z","date":"2020-06-10","kind":"grant","acquired":true,"shares":3427,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"8.3333% of the shares subject to the option shall vest on July 10, 2020, with the remainder vesting in equal monthly installments of 8.333% of the shares subject to the option until the 12-month anniversary of the date of the grant (or, if earlier, the date of the Issuer's next annual meeting of stockholders following the date of the grant) subject to the Reporting Person continuing to provide services through each such date."}],"balance_after":3427,"derivative":{"exercise_price":8.69,"expiration_date":"2030-06-09","underlying":"Common Stock","underlying_shares":3427},"source":{"system":"sec-edgar","filing":"0001628280-20-009240","document":"wf-form4_159187884350300.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501697/000162828020009240/wf-form4_159187884350300.xml","form_type":"4"}},{"id":3123280,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-03T20:26:32.000Z","date":"2020-05-18","kind":"sale","acquired":false,"shares":20000,"price":74.0161,"value":1480322.0,"ownership":{"direct":false,"nature":"By trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"These shares are held in a trust for the benefit of the Reporting Person's spouse and children. The Reporting Person's spouse and nephew are trustees of the trust."}],"balance_after":70350,"source":{"system":"sec-edgar","filing":"0001209191-20-034010","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120034010/doc4.xml","form_type":"4"}},{"id":3140470,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-05-20T23:50:39.000Z","date":"2020-05-18","kind":"exercise","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option was fully vested as of June 18, 2015."}],"balance_after":0,"derivative":{"exercise_price":40.37,"expiration_date":"2024-07-10","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-20-031055","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120031055/doc4.xml","form_type":"4"}},{"id":3140469,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-20T23:50:39.000Z","date":"2020-05-18","kind":"sale","acquired":false,"shares":7500,"price":74.65,"value":559875.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $74.62 to $74.70 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions."}],"balance_after":47924,"source":{"system":"sec-edgar","filing":"0001209191-20-031055","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120031055/doc4.xml","form_type":"4"}},{"id":3140468,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-05-20T23:50:39.000Z","date":"2020-05-18","kind":"exercise","acquired":true,"shares":7500,"price":40.37,"value":302775.0,"ownership":{"direct":true},"balance_after":55424,"source":{"system":"sec-edgar","filing":"0001209191-20-031055","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919120031055/doc4.xml","form_type":"4"}},{"id":3349595,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-12-06T17:45:10.000Z","date":"2019-12-04","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable on December 4, 2020."}],"balance_after":10000,"derivative":{"exercise_price":3.02,"expiration_date":"2029-12-04","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001273636-19-000043","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000127363619000043/edgar.xml","form_type":"4"}},{"id":3408788,"issuer":{"id":5638,"kind":"organization","name":"X4 Pharmaceuticals, Inc","symbol":"XFOR"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-09-20T20:52:03.000Z","date":"2019-09-18","kind":"grant","acquired":true,"shares":6854,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"8.3333% of the shares subject to the option shall vest on September 18, 2020, with the remainder vesting in equal monthly installments of 2.7777% of the shares underlying the initial grant until the 36-month anniversary of the date of the grant, subject the Reporting Person's continued service through each applicable vesting date."}],"balance_after":6854,"derivative":{"exercise_price":14.04,"expiration_date":"2029-09-18","underlying":"Common Stock","underlying_shares":6854},"source":{"system":"sec-edgar","filing":"0001209191-19-050347","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1501697/000120919119050347/doc4.xml","form_type":"4"}},{"id":3490997,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-13T21:00:06.000Z","date":"2019-06-11","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 11, 2020."}],"balance_after":5000,"derivative":{"exercise_price":58.74,"expiration_date":"2029-06-11","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-19-036832","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919119036832/doc4.xml","form_type":"4"}},{"id":3490996,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-13T21:00:06.000Z","date":"2019-06-11","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 11, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects transfers of directly owned shares of common stock to the Reporting Person's trusts that have taken place since the most recent prior report on Form 4."}],"balance_after":47924,"source":{"system":"sec-edgar","filing":"0001209191-19-036832","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919119036832/doc4.xml","form_type":"4"}},{"id":3726524,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-18T20:20:17.000Z","date":"2018-12-14","kind":"purchase","acquired":true,"shares":500,"price":3.24,"value":1620.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,500 shares held by the Reporting Person's wife in a self-directed IRA."}],"balance_after":8500,"source":{"system":"sec-edgar","filing":"0001273636-18-000085","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000127363618000085/edgar.xml","form_type":"4"}},{"id":3726523,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-18T20:20:17.000Z","date":"2018-12-14","kind":"purchase","acquired":true,"shares":4300,"price":3.25,"value":13975.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,500 shares held by the Reporting Person's wife in a self-directed IRA."}],"balance_after":8000,"source":{"system":"sec-edgar","filing":"0001273636-18-000085","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000127363618000085/edgar.xml","form_type":"4"}},{"id":3726522,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-18T20:20:17.000Z","date":"2018-12-14","kind":"purchase","acquired":true,"shares":1200,"price":3.235,"value":3882.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,500 shares held by the Reporting Person's wife in a self-directed IRA."}],"balance_after":3700,"source":{"system":"sec-edgar","filing":"0001273636-18-000085","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000127363618000085/edgar.xml","form_type":"4"}},{"id":3739079,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-12-07T21:12:38.000Z","date":"2018-12-07","kind":"sale","acquired":false,"shares":6000,"price":49.69,"value":298140.0,"ownership":{"direct":false,"nature":"By trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a trading plan adopted by the Reporting Person's trust pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held in a trust for the benefit of the reporting person's spouse and children. The reporting person's spouse and nephew are trustees of the trust."}],"balance_after":90350,"source":{"system":"sec-edgar","filing":"0001209191-18-061480","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919118061480/doc4.xml","form_type":"4"}},{"id":3758663,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-11-19T19:26:37.000Z","date":"2018-11-15","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable on November 15, 2019."}],"balance_after":10000,"derivative":{"exercise_price":6.9,"expiration_date":"2028-11-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001273636-18-000065","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000127363618000065/edgar.xml","form_type":"4"}},{"id":3770367,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-11-08T23:47:40.000Z","date":"2018-11-08","kind":"sale","acquired":false,"shares":6000,"price":55.67,"value":334020.0,"ownership":{"direct":false,"nature":"By trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported on this Form 4 was effected pursuant to a trading plan adopted by the Reporting Person's trust pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held in a trust for the benefit of the reporting person's spouse and children. The reporting person's spouse and nephew are trustees of the trust."}],"balance_after":96350,"source":{"system":"sec-edgar","filing":"0001209191-18-057820","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919118057820/doc4.xml","form_type":"4"}},{"id":3794099,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2018-10-09T20:36:57.000Z","date":"2014-02-05","kind":"exercise","acquired":false,"shares":266343,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each share of Series A Convertible Preferred Stock was convertible into Common Stock at any time and automatically converted into Common Stock on a 1-for-3.1345 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each share of Series A Convertible Preferred Stock was convertible into Common Stock at any time and automatically converted into Common Stock on a 1-for-3.1345 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each share of Series A Convertible Preferred Stock was convertible into Common Stock at any time and automatically converted into Common Stock on a 1-for-3.1345 basis immediately prior to the closing of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"The number of underlying shares of Common Stock reported in Column 7 reflects the automatic conversion of shares of Series A Preferred Stock into Common Stock on a 1-for-3.1345 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held in a trust for the benefit of the reporting person's spouse and children. The reporting person's spouse and nephew are trustees of the trust."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":84970},"source":{"system":"sec-edgar","filing":"0001209191-18-054531","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919118054531/doc4.xml","form_type":"4"}},{"id":3794098,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-09T20:36:57.000Z","date":"2018-10-08","kind":"sale","acquired":false,"shares":6000,"price":73.38,"value":440280.0,"ownership":{"direct":false,"nature":"By trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported on this Form 4 were effected pursuant to a trading plan adopted by the Reporting Person's trust pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held in a trust for the benefit of the reporting person's spouse and children. The reporting person's spouse and nephew are trustees of the trust."}],"balance_after":102350,"source":{"system":"sec-edgar","filing":"0001209191-18-054531","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919118054531/doc4.xml","form_type":"4"}},{"id":3794097,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stocki","published_at":"2018-10-09T20:36:57.000Z","date":"2018-04-19","kind":"sale","acquired":false,"shares":650,"price":53.97,"value":35080.5,"ownership":{"direct":false,"nature":"By trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held in a trust for the benefit of the reporting person's spouse and children. The reporting person's spouse and nephew are trustees of the trust."}],"balance_after":108350,"source":{"system":"sec-edgar","filing":"0001209191-18-054531","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919118054531/doc4.xml","form_type":"4"}},{"id":3794096,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-09T20:36:57.000Z","date":"2015-07-27","kind":"sale","acquired":false,"shares":400,"price":122.58,"value":49032.0,"ownership":{"direct":false,"nature":"By trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held in a trust for the benefit of the reporting person's spouse and children. The reporting person's spouse and nephew are trustees of the trust."}],"balance_after":109000,"source":{"system":"sec-edgar","filing":"0001209191-18-054531","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919118054531/doc4.xml","form_type":"4"}},{"id":3794095,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-09T20:36:57.000Z","date":"2015-05-27","kind":"sale","acquired":false,"shares":2000,"price":85.94,"value":171880.0,"ownership":{"direct":false,"nature":"By trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held in a trust for the benefit of the reporting person's spouse and children. The reporting person's spouse and nephew are trustees of the trust."}],"balance_after":109400,"source":{"system":"sec-edgar","filing":"0001209191-18-054531","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919118054531/doc4.xml","form_type":"4"}},{"id":3794094,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-09T20:36:57.000Z","date":"2015-05-12","kind":"sale","acquired":false,"shares":10500,"price":68.65,"value":720825.0,"ownership":{"direct":false,"nature":"By trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held in a trust for the benefit of the reporting person's spouse and children. The reporting person's spouse and nephew are trustees of the trust."}],"balance_after":111400,"source":{"system":"sec-edgar","filing":"0001209191-18-054531","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919118054531/doc4.xml","form_type":"4"}},{"id":3794093,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-09T20:36:57.000Z","date":"2014-02-05","kind":"exercise","acquired":true,"shares":84970,"ownership":{"direct":false,"nature":"By trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The number of shares of Common Stock reported reflects the automatic conversion of shares of Series A Preferred Stock into Common Stock on a 1-for-3.1345 basis immediately prior to the closing of the Issuer's initial public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held in a trust for the benefit of the reporting person's spouse and children. The reporting person's spouse and nephew are trustees of the trust."}],"balance_after":121900,"source":{"system":"sec-edgar","filing":"0001209191-18-054531","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919118054531/doc4.xml","form_type":"4"}},{"id":3808982,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-09-24T21:46:21.000Z","date":"2018-09-20","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable in equal yearly installments over three years from the date of grant."}],"balance_after":25000,"derivative":{"exercise_price":4.4,"expiration_date":"2028-09-20","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001273636-18-000056","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000127363618000056/edgar.xml","form_type":"4"}},{"id":3849425,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-08T21:32:01.000Z","date":"2018-08-08","kind":"sale","acquired":false,"shares":3750,"price":76.66,"value":287475.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.6600 to $76.6622 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":72610,"source":{"system":"sec-edgar","filing":"0001209191-18-045878","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919118045878/doc4.xml","form_type":"4"}},{"id":3886918,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-20T21:50:46.000Z","date":"2018-06-19","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 19, 2019."}],"balance_after":5000,"derivative":{"exercise_price":80.69,"expiration_date":"2028-06-19","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-18-038835","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919118038835/doc4.xml","form_type":"4"}},{"id":3886917,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-20T21:50:46.000Z","date":"2018-06-19","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 19, 2019."}],"balance_after":76360,"source":{"system":"sec-edgar","filing":"0001209191-18-038835","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919118038835/doc4.xml","form_type":"4"}},{"id":4089505,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-01-25T22:07:24.000Z","date":"2018-01-23","kind":"exercise","acquired":false,"shares":11500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3 of the shares initially subject to the option vested one year from January 30, 2014 and then 1/36 of the shares initially subject to the option began vesting monthly thereafter."}],"balance_after":0,"derivative":{"exercise_price":21,"expiration_date":"2024-01-29","underlying":"Common Stock","underlying_shares":11500},"source":{"system":"sec-edgar","filing":"0001209191-18-005421","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919118005421/doc4.xml","form_type":"4"}},{"id":4089504,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-25T22:07:24.000Z","date":"2018-01-23","kind":"exercise","acquired":true,"shares":11500,"price":21,"value":241500.0,"ownership":{"direct":true},"balance_after":73360,"source":{"system":"sec-edgar","filing":"0001209191-18-005421","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919118005421/doc4.xml","form_type":"4"}},{"id":4274245,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-06-22T23:17:00.000Z","date":"2017-06-22","kind":"grant","acquired":true,"shares":3750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 22, 2018."}],"balance_after":3750,"derivative":{"exercise_price":65.66,"expiration_date":"2027-06-22","underlying":"Common Stock","underlying_shares":3750},"source":{"system":"sec-edgar","filing":"0001209191-17-041466","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919117041466/doc4.xml","form_type":"4"}},{"id":4274244,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-22T23:17:00.000Z","date":"2017-06-22","kind":"grant","acquired":true,"shares":1875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Award of Restricted Stock Units (\"RSUs\") under the Company's 2014 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) June 22, 2018."}],"balance_after":61860,"source":{"system":"sec-edgar","filing":"0001209191-17-041466","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000120919117041466/doc4.xml","form_type":"4"}},{"id":4532746,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2016-12-05T22:39:17.000Z","date":"2016-12-05","kind":"exercise","acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3 of the shares initially subject to the option vested one year from January 30, 2014 and then 1/36 of the shares initially subject to the option began vesting monthly thereafter."}],"balance_after":11500,"derivative":{"exercise_price":21,"expiration_date":"2024-01-29","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001562180-16-003674","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000156218016003674/primarydocument.xml","form_type":"4"}},{"id":4532745,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-05T22:39:17.000Z","date":"2016-12-05","kind":"sale","acquired":false,"shares":2000,"price":78.7,"value":157400.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.60 to $78.75 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":59985,"source":{"system":"sec-edgar","filing":"0001562180-16-003674","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000156218016003674/primarydocument.xml","form_type":"4"}},{"id":4532744,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-05T22:39:17.000Z","date":"2016-12-05","kind":"sale","acquired":false,"shares":4000,"price":77.94,"value":311760.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $77.60 to $78.51 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":61985,"source":{"system":"sec-edgar","filing":"0001562180-16-003674","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000156218016003674/primarydocument.xml","form_type":"4"}},{"id":4532743,"issuer":{"id":4337,"kind":"organization","name":"Ultragenyx Pharmaceutical Inc.","symbol":"RARE"},"owners":[{"id":90042,"kind":"person","name":"Aliski William","position":1,"cik":"0001598426","reported_name":"Aliski William","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-05T22:39:17.000Z","date":"2016-12-05","kind":"exercise","acquired":true,"shares":6000,"price":21,"value":126000.0,"ownership":{"direct":true},"balance_after":65985,"source":{"system":"sec-edgar","filing":"0001562180-16-003674","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1515673/000156218016003674/primarydocument.xml","form_type":"4"}}]}